A new biomarker function for a long-known hormone

Plasma adiponectin is a potential biomarker for organ involvement in male Fabry disease patients

Adiponectin is a hormone with well-known relevance to cardiac and renal function. As Fabry disease (FD), a rare metabolic disorder, often manifests with cardiac and/or renal symptoms, researchers at CENTOGENE examined a potential link to adiponectin. Their finding of plasma adiponectin levels to correlate with heart and kidney damage in FD patients were published in the journal Blood Cells, Molecules, and Diseases.


  • Marina Hovakimyan , PhD
  • VAN Talabattula
  • Dr. rer. nat. Claudia Cozma , MD
  • Christian Beetz
  • Prof. Arndt Rolfs , MD
  • Deborah Elstein